CN103816468B - 一种治疗胃癌的胶囊及其制备方法 - Google Patents
一种治疗胃癌的胶囊及其制备方法 Download PDFInfo
- Publication number
- CN103816468B CN103816468B CN201410106073.9A CN201410106073A CN103816468B CN 103816468 B CN103816468 B CN 103816468B CN 201410106073 A CN201410106073 A CN 201410106073A CN 103816468 B CN103816468 B CN 103816468B
- Authority
- CN
- China
- Prior art keywords
- radix
- gastric cancer
- herba
- fructus
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 53
- 239000002775 capsule Substances 0.000 title claims abstract description 53
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 53
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 75
- 210000003038 endothelium Anatomy 0.000 claims abstract description 23
- 241000244155 Taenia Species 0.000 claims abstract description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000009835 boiling Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 45
- 239000002994 raw material Substances 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- RHAXKFFKGZJUOE-UHFFFAOYSA-N 7-acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid Chemical compound O=C1C2=CC(O)=C(C(O)=O)C(C(O)=O)=C2C(=O)C2=C1C(O)=C(CC)C(C(C)=O)=C2O RHAXKFFKGZJUOE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 68
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 37
- 208000026435 phlegm Diseases 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 36
- 235000019640 taste Nutrition 0.000 abstract description 12
- 238000005728 strengthening Methods 0.000 abstract description 8
- 231100000957 no side effect Toxicity 0.000 abstract description 6
- 230000001093 anti-cancer Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000006071 cream Substances 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 40
- 210000002784 stomach Anatomy 0.000 description 35
- 210000000952 spleen Anatomy 0.000 description 28
- 229940079593 drug Drugs 0.000 description 25
- 231100000614 poison Toxicity 0.000 description 23
- 210000004072 lung Anatomy 0.000 description 22
- 206010011224 Cough Diseases 0.000 description 19
- 206010047700 Vomiting Diseases 0.000 description 18
- 230000008673 vomiting Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 230000001105 regulatory effect Effects 0.000 description 14
- 206010000087 Abdominal pain upper Diseases 0.000 description 13
- 239000003172 expectorant agent Substances 0.000 description 13
- 230000003419 expectorant effect Effects 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 13
- 201000011510 cancer Diseases 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 241000721047 Danaus plexippus Species 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 8
- 206010040943 Skin Ulcer Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 231100000019 skin ulcer Toxicity 0.000 description 8
- 206010017553 Furuncle Diseases 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 206010067171 Regurgitation Diseases 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 230000001174 ascending effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 201000006549 dyspepsia Diseases 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 206010000077 Abdominal mass Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 208000001431 Psychomotor Agitation Diseases 0.000 description 6
- 206010038743 Restlessness Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 5
- 208000000616 Hemoptysis Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 230000001605 fetal effect Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010043458 Thirst Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000004528 Catalpa ovata Species 0.000 description 2
- 235000010005 Catalpa ovata Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019705 Hepatic pain Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010027457 Metastases to liver Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 241001116495 Taxaceae Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000001983 lactogenic effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 208000013433 lightheadedness Diseases 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 230000000505 pernicious effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000050510 Cunninghamia lanceolata Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 208000002375 Hand-Foot Syndrome Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000258241 Mantis Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000162450 Taxus cuspidata Species 0.000 description 1
- 235000009065 Taxus cuspidata Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960004117 capecitabine Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940084651 iressa Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 230000001855 preneoplastic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
序号 | 年龄 | 性别 | 服用前肿瘤大小 | 服药时间 | 服用后肿瘤大小 |
1 | 45 | 男 | 肿瘤直径23mm | 2个月 | 肿瘤直径13mm |
2 | 60 | 男 | 肿瘤直径20mm | 2个月 | 肿瘤直径15mm |
3 | 43 | 女 | 肿瘤直径10mm | 1个月 | 肿瘤直径10mm |
4 | 51 | 男 | 肿瘤直径22mm | 3个月 | 肿瘤直径8mm |
5 | 50 | 男 | 肿瘤直径33mm | 2个月 | 肿瘤直径12mm |
6 | 54 | 男 | 肿瘤直径37mm | 2个月 | 肿瘤直径15mm |
7 | 45 | 男 | 肿瘤直径45mm | 3个月 | 肿瘤直径20mm |
8 | 48 | 女 | 肿瘤直径25mm | 2个月 | 肿瘤直径24mm |
9 | 48 | 男 | 肿瘤直径35mm | 4个月 | 肿瘤直径10mm |
10 | 55 | 男 | 肿瘤直径33mm | 2个月 | 肿瘤直径30mm |
11 | 52 | 男 | 肿瘤直径28mm | 1个月 | 肿瘤直径30mm |
12 | 49 | 男 | 肿瘤直径22mm | 1个月 | 肿瘤直径25mm |
13 | 47 | 女 | 肿瘤直径30mm | 2个月 | 肿瘤直径25mm |
14 | 55 | 男 | 肿瘤直径26mm | 2个月 | 肿瘤直径20mm |
15 | 51 | 男 | 肿瘤直径34mm | 2个月 | 肿瘤直径30mm |
16 | 53 | 男 | 肿瘤直径36mm | 2个月 | 肿瘤直径34mm |
17 | 63 | 男 | 肿瘤直径30mm | 3个月 | 肿瘤直径27mm |
18 | 54 | 男 | 肝转移灶直径20mm | 2个月 | 肝转移灶直径18mm |
19 | 55 | 男 | 肿瘤直径36mm | 2个月 | 肿瘤直径34mm |
20 | 41 | 男 | 肿瘤直径35mm | 3个月 | 肿瘤直径27mm |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410106073.9A CN103816468B (zh) | 2014-03-21 | 2014-03-21 | 一种治疗胃癌的胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410106073.9A CN103816468B (zh) | 2014-03-21 | 2014-03-21 | 一种治疗胃癌的胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103816468A CN103816468A (zh) | 2014-05-28 |
CN103816468B true CN103816468B (zh) | 2016-08-31 |
Family
ID=50751948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410106073.9A Active CN103816468B (zh) | 2014-03-21 | 2014-03-21 | 一种治疗胃癌的胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103816468B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101804171A (zh) * | 2010-05-13 | 2010-08-18 | 白如冰 | 一种治疗胃癌的药物 |
-
2014
- 2014-03-21 CN CN201410106073.9A patent/CN103816468B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101804171A (zh) * | 2010-05-13 | 2010-08-18 | 白如冰 | 一种治疗胃癌的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN103816468A (zh) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
CN101342271B (zh) | 医治肿瘤化疗引起的气血两虚的中药及制备方法 | |
CN104524335B (zh) | 一种用于女性内分泌失调调理的药丸及制备方法 | |
CN103920034A (zh) | 减轻肿瘤病人化疗副反应的中药组合物及制法 | |
CN103432412B (zh) | 一种治疗乳腺增生的药物及其制备方法 | |
CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
CN104069162A (zh) | 一种治疗痛风性关节炎及各种骨关节疼痛的中药 | |
CN105535495A (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN100431595C (zh) | 用于气滞寒凝胃痛的药物组合物及其制备方法和用途 | |
CN103908616B (zh) | 缓解肿瘤病人放疗反应的药剂及制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN103212026B (zh) | 一种治疗胆石症的中药及其制备方法和服用方法 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN105749172A (zh) | 一种治疗胃结石的药物及其制备 | |
CN105343866A (zh) | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 | |
CN103816468B (zh) | 一种治疗胃癌的胶囊及其制备方法 | |
CN103860960B (zh) | 一种治疗乳腺癌的胶囊及其制备方法 | |
CN103977279A (zh) | 一种治疗母猪子宫炎的中药添加剂及其制备方法 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN103893328A (zh) | 一种治疗乳腺增生的中药药丸 | |
CN106692821A (zh) | 一种治疗神经外科术后头痛的中药制剂 | |
CN105456951A (zh) | 一种治疗乳房纤维腺瘤的中药制剂及其制备方法 | |
CN105327066A (zh) | 一种制备治疗产后缺乳的中药组合物的方法 | |
CN105031389A (zh) | 一种配合放疗法抑制恶性肿瘤繁殖的中药片剂及制法 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160125 Address after: 150040 Heilongjiang Province, Harbin city Xiangfang district two street 1 Civil Building No. 3 1 floor No. 18 Applicant after: Harbin Guyuan Technology Development Co., Ltd. Address before: 150040 Heping Road, Xiangfang District, Heilongjiang, Harbin, China, 26 Applicant before: Jiang Jiakang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Capsule for treating stomach cancer and preparation method thereof Effective date of registration: 20171218 Granted publication date: 20160831 Pledgee: Harbin Jinsheng science and Technology Development Co., Ltd. Pledgor: Harbin Guyuan Technology Development Co., Ltd. Registration number: 2017230000010 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200119 Granted publication date: 20160831 Pledgee: Harbin Jinsheng science and Technology Development Co., Ltd. Pledgor: Harbin Guyuan Technology Development Co., Ltd. Registration number: 2017230000010 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200325 Address after: 150040 No.105, floor 1, building a, block B (famous city of Chunjiang), phase II, Chunjiang homestead, Harbin City, Heilongjiang Province Patentee after: Harbin jutongtang Technology Co., Ltd Address before: 150040 Heilongjiang Province, Harbin city Xiangfang district two street 1 Civil Building No. 3 1 floor No. 18 Patentee before: HARBIN GUYUAN TECHNOLOGY DEVELOPMENT Co.,Ltd. |